Position Statement on Intra-Articular Injections for Knee Osteoarthritis – 2019
The management of knee osteoarthritis and degenerative meniscal tears is multimodal. A key component to the non-operative management of these conditions involves intra-articular injection therapy. The injections available in Canada include: corticosteroids, hyaluronic acid (HA), platelet rich plasma (PRP), and stem cell injections including bone marrow aspirate concentrate (BMAC). The Arthroscopy Association of Canada (AAC), Canadian Arthroplasty Society (CAS) and Canadian Orthopaedic Association (COA) recently reviewed the most up to date evidence on the use of these injections.
See below for a brief synopsis of findings and recommendations, as well as the complete AAC position statement, with associated grades of recommendations and references.
Position Statement Concerning Arthroscopy of the Knee Joint – 2017
This position statement was prepared in response to increased attention in the media and amongst health authorities as to the role of arthroscopy in knees with and without x-ray evidence of osteoarthritis (OA). While recognizing that there is a gap between scientific evidence and clinical practice, the purpose of this statement is to outline current best practice guidelines, taking into consideration the available evidence as well as the clinical knowledge of experienced surgeons. It is meant to be a guideline for the practice of arthroscopy while allowing for individual decision making by the surgeon and the patient after considering all risks and benefits of any procedure. The position statement was endorsed and approved by the COA Board of Directors in January 2018. Click below to see the full position statement in English or French.